Cornual fibroids: a conservative approach to restoring tubal patency using a gonadotropin-releasing hormone agonist (goserelin) with successful pregnancy

Fertil Steril. 1989 Aug;52(2):332-4. doi: 10.1016/s0015-0282(16)60865-8.

Abstract

The administration of GnRH agonists to shrink fibroids, albeit temporarily, may be of benefit to those patients in whom tubal blockage by the fibroids has given rise to infertility. Tubal patency has been restored in two of our patients, resulting in pregnancy in one.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Buserelin / analogs & derivatives*
  • Buserelin / therapeutic use
  • Fallopian Tube Patency Tests
  • Fallopian Tubes / drug effects*
  • Fallopian Tubes / physiopathology
  • Female
  • Fibroma / drug therapy*
  • Goserelin
  • Humans
  • Pregnancy
  • Uterine Neoplasms / drug therapy*

Substances

  • Goserelin
  • Buserelin